Biomerica, Inc. (NASDAQ:BMRA – Get Free Report) was the recipient of a significant increase in short interest in November. As of November 30th, there was short interest totalling 1,430,000 shares, an increase of 284.7% from the November 15th total of 371,700 shares. Based on an average daily volume of 844,900 shares, the short-interest ratio is presently 1.7 days.
Biomerica Trading Down 0.6 %
BMRA traded down $0.00 during midday trading on Friday, hitting $0.29. The company had a trading volume of 46,430 shares, compared to its average volume of 406,064. Biomerica has a 52 week low of $0.24 and a 52 week high of $2.13. The stock’s 50 day moving average price is $0.34 and its 200 day moving average price is $0.38.
Biomerica (NASDAQ:BMRA – Get Free Report) last posted its quarterly earnings results on Tuesday, October 15th. The company reported ($0.08) earnings per share for the quarter. Biomerica had a negative net margin of 111.89% and a negative return on equity of 84.62%. The company had revenue of $1.81 million during the quarter.
Institutional Investors Weigh In On Biomerica
Biomerica Company Profile
Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.
Further Reading
- Five stocks we like better than Biomerica
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- 3 Consumer Discretionary Stocks Ready for a Comeback in 2025
- Market Cap Calculator: How to Calculate Market Cap
- Top 3 Robotics and Automation Stocks for the Next AI Boom
- 3 Monster Growth Stocks to Buy Now
- Why a Stock Split Could Be a Game-Changer for Casey’s in 2025
Receive News & Ratings for Biomerica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biomerica and related companies with MarketBeat.com's FREE daily email newsletter.